Serum FBLN1 and STK31 as biomarkers of colorectal cancer and their ability to noninvasively differentiate colorectal cancer from benign polyps
Conclusion FBLN1 and STK31 can be possible screening and differentiating biomarkers of CRC.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Gastrointestinal Polyps | Polyps | Study